Cellular Dynamics International Announces Agreement With AstraZeneca PLC on Use of iPSC-derived Human Cells in Drug Discovery Research

MADISON, Wis., Jan. 3, 2013 /PRNewswire/ -- Cellular Dynamics International, Inc. (CDI) today announced a Center of Excellence agreement with AstraZeneca to accelerate the pace of drug discovery throu…
Read the full story: BioSpace.com Featured News